Literature DB >> 10534766

Nonrandom chromosomal aberrations and cytogenetic heterogeneity in gallbladder carcinomas.

L Gorunova1, L A Parada, J Limon, Y Jin, M Hallén, I Hägerstrand, M Iliszko, Z Wajda, B Johansson.   

Abstract

Chromosome banding analysis of 11 short-term cultured gallbladder carcinomas revealed acquired clonal aberrations in seven tumors (five primary and two metastases). Three of these had one clone, whereas the remaining four were cytogenetically heterogeneous, displaying two to seven aberrant clones. Of a total of 21 abnormal clones, 18 had highly complex karyotypes and three exhibited simple numerical deviations. Double minutes and homogeneously staining regions were observed in one and two carcinomas, respectively. To characterize the karyotypic profile of gallbladder cancer more precisely, we have combined the present findings with our three previously reported cases, thereby providing the largest cytogenetic database on this tumor type to date. A total of 287 chromosomal breakpoints were identified, 251 of which were found in the present study. Chromosome 7 was rearranged most frequently, followed by chromosomes 1, 3, 11, 6, 5, and 8. The bands preferentially involved were 1p32, 1p36, 1q32, 3p21, 6p21, 7p13, 7q11, 7q32, 19p13, 19q13, and 22q13. Nine recurrent abnormalities could, for the first time, be identified in gallbladder carcinoma: del(3)(p13), i(5)(p10), del(6)(q13), del(9)(p13), del(16)(q22), del(17)(p11), i(17)(q10), del(19)(p13), and i(21)(q10). The most common partial or whole-arm gains involved 3q, 5p, 7p, 7q, 8q, 11q, 13q, and 17q, and the most frequent partial or whole-arm losses affected 3p, 4q, 5q, 9p, 10p, 10q, 11p, 14p, 14q, 15p, 17p, 19p, 21p, 21q, and Xp. These chromosomal aberrations and imbalances provide some starting points for molecular analyses of genomic regions that may harbor genes of pathogenetic importance in gallbladder carcinogenesis. Genes Chromosomes Cancer 26:312-321, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10534766     DOI: 10.1002/(sici)1098-2264(199912)26:4<312::aid-gcc5>3.0.co;2-3

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

Review 1.  Genetics of biliary tract cancers and emerging targeted therapies.

Authors:  Aram F Hezel; Vikram Deshpande; Andrew X Zhu
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

Review 2.  Aspects of digestive tract tumors in Down syndrome: a literature review.

Authors:  Daniel Satgé; Annie J Sasco; Michel J J Vekemans; Marie-Laure Portal; Jean-François Fléjou
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

3.  CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells.

Authors:  Jian-Hua Yu; Xiang-Yu Zhong; Wei-Guang Zhang; Zhi-Dong Wang; Qin Dong; Sheng Tai; Hui Li; Yun-Fu Cui
Journal:  Oncol Rep       Date:  2011-12-30       Impact factor: 3.906

4.  BCL6 overexpression is associated with decreased p19 ARF expression and confers an independent prognosticator in gallbladder carcinoma.

Authors:  Peir-In Liang; Chien-Feng Li; Li-Tzong Chen; Ding-Ping Sun; Tzu-Ju Chen; Chung-Hsi Hsing; Han-Ping Hsu; Ching-Yih Lin
Journal:  Tumour Biol       Date:  2013-10-11

5.  Refined pancreatobiliary UroVysion criteria and an approach for further optimization.

Authors:  Daniel Mettman; Azhar Saeed; Janna Shold; Raquele Laury; Andrew Ly; Irfan Khan; Shivani Golem; Mojtaba Olyaee; Maura O'Neil
Journal:  Cancer Med       Date:  2021-08-10       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.